University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.
Swiss Med Wkly. 2012 Feb 3;142:w13515. doi: 10.4414/smw.2012.13515. eCollection 2012.
In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.
在冠状动脉疾病中，心血管风险因素是一级和二级预防的主要目标。他汀类药物可预防高危患者的心血管事件。然而，尽管他汀类药物已被证实具有疗效和安全性，但仍存在相关的副作用，在治疗患者时应予以考虑。
